Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 1996

View Archived Issues

Ethical's sustained-release morphine sublicensed for Canada

Antimicrobial peptide combinations available for licensing

Methods for screening for neurotoxicity offered for licensing

Frog peptides with antimicrobial activity available for licensing

Novel porphycene compounds synthesized at Cytopharm

Dual-action PDE IV/TNF-alpha inhibitors reported by Janssen

Lilly research into antiobesity proteins continues

Therapeutically active NPY analogues reported by Salk Institute

Antihyperlipidemic agents from natural source described by Takeda

Potent ACAT inhibitor discovered by Kitasato Institute

Antiproliferative agents disclosed by Kitasato Institute

New anxiolytic under development at Parke-Davis

Antiepileptic agent reported by Parke-Davis

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Axcan-Schwarz joint venture to market URSO

Ivermectin approved for use in humans

SuperGen-Galenica anticancer drug collaboration

Expanded patent portfolio for Dyax technology

Lidak reacquires certain rights to Lidakol from BMS

Antiepileptic drug from Neurogen licensed to Wyeth-Ayerst

Patent issued for method of diagnosing and treating impotence

Incyte-Affymetrix to develop and commercialize new chip-based genomic databases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...